Today's Law As Amended

PDF |Add To My Favorites |Track Bill | print page

SB-305 Compassionate Access to Medical Cannabis Act or Ryan’s Law.(2019-2020)



SECTION 1.

 Chapter 4.9 (commencing with Section 1649) is added to Division 2 of the Health and Safety Code, to read:

CHAPTER  4.9. Compassionate Access to Medical Cannabis Act or Ryan’s Law
1649.
 (a) This chapter shall be known, and may be cited, as the “Compassionate Access to Medical Cannabis Act” or “Ryan’s Law.”
(b) It is the intent of the Legislature in enacting this chapter to support the ability of a terminally ill patient to safely use medical cannabis within specified health care facilities in compliance with the Compassionate Use Act of 1996 and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10.
1649.5.
 Unless the context requires otherwise, the following definitions shall apply to this chapter:
(a) “Compassionate Use Act of 1996” means the initiative measure enacted by the approval of Proposition 215 at the November 5, 1996, statewide general election and found at Section 11362.5, and any amendments to that act.
(b) (1) Except as provided in paragraph (2), “health care facility” means a health facility specified in subdivision (a), (c), (f), (i), or (n) of Section 1250.
(2) The meaning of “health care facility” shall not include a chemical dependency recovery hospital or a state hospital.
(c) “Medical cannabis” means cannabis or a cannabis product used in compliance with the Compassionate Use Act of 1996 and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10.
(d) “Patient” means an individual who is terminally ill.
(e) “Terminally ill” means a medical condition resulting in a prognosis of life of one year or less, if the disease follows its natural course.
1649.10.
 A health care facility shall do all of the following:
(a) Not interfere or prohibit a patient from using medical cannabis within the health care facility.
(b) Prohibit smoking or vaping as methods to use medical cannabis.
(c) Include the use of medical cannabis within the patient’s medical records.
(d) Require a patient to provide a copy of the patient’s valid identification card as described in Section 11362.715 or a copy of that patient’s written documentation as defined in Section 11362.7.
(e) Develop and disseminate written guidelines for the use of medical cannabis within the health care facility pursuant to this chapter.
(f) This section does not apply to a patient receiving emergency services and care, as defined in Section 1317.1, or to the emergency department of a health care facility, as specified in subdivision (a) of Section 1250, while the patient is receiving emergency services and care.
1649.15.
 A health care facility may reasonably restrict the manner in which a patient stores and uses medical cannabis, including requiring the medical cannabis to be stored in a locked container, to ensure the safety of other patients, guests, and employees of the health care facility, compliance with other state laws, and the safe operations of the health care facility. A health care facility may specify that it is not responsible for lost or stolen medical cannabis. A health care facility shall include all restrictions within the written guidelines required by Section 1649.10.
1649.20.
 This chapter does not require a health care facility to provide a patient with a recommendation to use medical cannabis in compliance with the Compassionate Use Act of 1996 and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 or include medical cannabis in a patient’s discharge plan.
1649.25.
 (a) This chapter shall not be enforced by the department that licenses the health care facility.
(b) Compliance with this chapter shall not be a condition for obtaining, retaining, or renewing a license as a health care facility.
(c) This chapter does not reduce, expand, or otherwise modify the laws restricting the cultivation, possession, distribution, or use of cannabis that may be otherwise applicable, including, but not limited to, the Control, Regulate and Tax Adult Use of Marijuana Act, an initiative measure enacted by the approval of Proposition 64 at the November 8, 2016, statewide general election, and any amendments to that act.
1649.30.
 (a) If a federal regulatory agency, the United States Department of Justice (US DOJ), or the federal Centers for Medicare and Medicaid Services (CMS) takes one of the following actions, a health care facility may suspend compliance with Section 1649.10 until the regulatory agency, the US DOJ, or CMS notifies the health care facility that it may resume permitting the use of medical cannabis within the facility:
(1) A federal regulatory agency or the US DOJ initiates enforcement action against a health care facility related to the facility’s compliance with a state-regulated medical marijuana program.
(2) A federal regulatory agency, the US DOJ, or CMS issues a rule or otherwise provides notification to the health care facility that expressly prohibits the use of medical marijuana in health care facilities or otherwise prohibits compliance with a state-regulated medical marijuana program.
(b) This section does not permit a health care facility to prohibit the use of medical cannabis due solely to the fact that cannabis is a Schedule I drug pursuant to the federal Uniform Controlled Substances Act, or other federal constraints on the use of medical marijuana that were in existence prior to the enactment of this chapter.